Quote: "Third member of prestigious FDA panel res
Post# of 148147
(Total Views: 506)
Posted On: 06/11/2021 12:19:18 PM
Re: discoveryy #93410
Quote:
"Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug"
This makes me wonder if someone well educated on such things could put together a comparison of the data the FDA used to support approval for Biogen's drug juxtaposed to LL's data that was rejected, i.e., 30% brain swelling/bleeding vs. zero SAEs for LL, etc.?
Just a thought from the uneducated, but moderately invested.
"Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug"
This makes me wonder if someone well educated on such things could put together a comparison of the data the FDA used to support approval for Biogen's drug juxtaposed to LL's data that was rejected, i.e., 30% brain swelling/bleeding vs. zero SAEs for LL, etc.?
Just a thought from the uneducated, but moderately invested.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼